HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 11/2/45    most recent 00064.2002v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (12) Citing Articles via Google Scholar Google Scholar Articles by Sarang, S. S. Articles by Gullans, S. R. Search for Related Content PubMed PubMed Citation Articles by Sarang, S. S. Articles by Gullans, S. R.

Discovery of molecular mechanisms of neuroprotection using cell-based bioassays and oligonucleotide arrays

Biotechnology Center, Center for Neurologic Diseases, Brigham and Women’s Hospital, Harvard Medical School, Cambridge, Massachusetts 02139

Oxidative injury and the resulting death of neurons is a major pathological factor involved in numerous neurodegenerative diseases. However, the development of drugs that target this mechanism remains limited. The goal of this study was to test a compound library of approved Food and Drug Administration drugs against a hydrogen peroxide-induced oxidant injury model in neuroblastoma cells. We identified 26 neuroprotective compounds, of which megestrol, meclizine, verapamil, methazolamide, sulindac, and retinol were examined in greater detail. Using large-scale oligonucleotide microarray analysis, we identified genes modulated by these drugs that might underlie the cytoprotection. Five key genes were either uniformly upregulated or downregulated by all six drug treatments, namely, tissue inhibitor of matrix metalloproteinase (TIMP1), ret-proto-oncogene, clusterin, galanin, and growth associated protein (GAP43). Exogenous addition of the neuropeptide galanin alone conferred survival to oxidant-stressed cells, comparable to that seen with the drugs. Our approach, which we term "interventional profiling," represents a general and powerful strategy for identifying new bioactive agents for any biological process, as well as identifying key downstream genes and pathways that are involved.

oxidative stress; galanin

This article has been cited by other articles:

				X. Wang, B. E. Figueroa, I. G. Stavrovskaya, Y. Zhang, A. C. Sirianni, S. Zhu, A. L. Day, B. S. Kristal, and R. M. Friedlander Methazolamide and Melatonin Inhibit Mitochondrial Cytochrome C Release and Are Neuroprotective in Experimental Models of Ischemic Injury Stroke, May 1, 2009; 40(5): 1877 - 1885. [Abstract] [Full Text] [PDF]

				X. Wang, S. Zhu, Z. Pei, M. Drozda, I. G. Stavrovskaya, S. J. Del Signore, K. Cormier, E. M. Shimony, H. Wang, R. J. Ferrante, et al. Inhibitors of Cytochrome c Release with Therapeutic Potential for Huntington's Disease J. Neurosci., September 17, 2008; 28(38): 9473 - 9485. [Abstract] [Full Text] [PDF]

				N. Strunnikova, C. Zhang, D. Teichberg, S. W. Cousins, J. Baffi, K. G. Becker, and K. G. Csaky Survival of Retinal Pigment Epithelium after Exposure to Prolonged Oxidative Injury: A Detailed Gene Expression and Cellular Analysis Invest. Ophthalmol. Vis. Sci., October 1, 2004; 45(10): 3767 - 3777. [Abstract] [Full Text] [PDF]

				T. Takahashi, B. Lord, P. C. Schulze, R. M. Fryer, S. S. Sarang, S. R. Gullans, and R. T. Lee Ascorbic Acid Enhances Differentiation of Embryonic Stem Cells Into Cardiac Myocytes Circulation, April 15, 2003; 107(14): 1912 - 1916. [Abstract] [Full Text] [PDF]